A new study suggests that a key group of transcription factors are 'druggable,' including several that could be targeted to treat cancer, metabolic disease, or autoimmune conditions.
CURRENT ISSUE - March/2026
How Lab Leaders Can Prepare for Safety Crises That Don’t Follow the Script